What is Becton, Dickinson and Company's medical essentials — D&A?

Becton, Dickinson and Company (BDX) reported medical essentials — D&A of $147M in Q1 2026.

What does medical essentials — D&A mean?

This metric reflects the non-cash expense allocated to the Medical Essentials segment for the wear and tear of tangible assets and the amortization of intangible assets over their useful lives. It provides insight into the capital intensity of the segment's manufacturing operations and the historical investment in technology or acquisitions. Monitoring this helps analysts understand the segment's underlying cash flow generation capacity versus reported accounting earnings.

Becton, Dickinson and Company BDX Medical Essentials — D&A

Other segment segments

Medical

$1.39B+14.6%

Connected Care

$194M-2.5%

Interventional

$192M-3.0%

BioPharma Systems

$27M-15.6%

Similar metrics at other companies

MIRMedical Segment — D&A

$16.2M-1.2%

NOVTMedical Solutions — D&A

$9.58M+24.7%

ASSTMedical Device — D&A

$32K—

JNJMedical Devices — D&A

$903M+8.0%

WLKPerformance and Essential Materials Segment — D&A

$13M0.0%

WLKPerformance and Essential Materials — D&A

$221M-2.6%

Other financials

Income statement

See full

Revenue$4.7B+5.2%

Gross profit$2.2B+15.7%

Operating income$93.0M-75.7%

Net income-$311.0M-201%

EPS (diluted)-$1.11-204%

Balance sheet

See full

Cash & equivalents$1.0B+49.0%

Total debt$14.7B-16.8%

Total equity$24.1B-4.4%

Total assets$50.8B-6.7%

Cash flow

See full

Operating cash flow$671.0M—

CapEx$125.0M+9.6%

Free cash flow$546.0M—

Valuation

See full

Market cap$42.96B-12.6%

Enterprise value$56.65B-14.0%

P/E37.8×+6.7×

P/S2×-0.4×

Profitability

See full

Gross margin46.8%+2.5pp

Operating margin10.4%+0.1pp

Net margin5.3%-2.1pp

FCF margin16.4%—

Returns & leverage

See full

Return on equity4.6%-1.3pp

Debt / equity0.6×-0.1×

Current ratio0.9×-0.2×

Where this comes from

Reported directly by Becton, Dickinson and Company in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Becton, Dickinson and Company's medical essentials — d&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Becton, Dickinson and Company's medical essentials — D&A?: Becton, Dickinson and Company (BDX) reported medical essentials — D&A of $147M in Q1 2026.
What does medical essentials — D&A mean?: This metric reflects the non-cash expense allocated to the Medical Essentials segment for the wear and tear of tangible assets and the amortization of intangible assets over their useful lives. It provides insight into the capital intensity of the segment's manufacturing operations and the historical investment in technology or acquisitions. Monitoring this helps analysts understand the segment's underlying cash flow generation capacity versus reported accounting earnings.